NEW YORK, Oct. 21, 2020 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
Cleveland BioLabs, Inc. (NASDAQ: CBLI) and its board of directors
concerning the proposed acquisition of the company by Cytocom, Inc.
Cleveland BioLabs stockholders are expected to own 39% of the
combined company. The Transaction is expected to close in the first
quarter of 2021.
If you are a stockholder of Cleveland BioLabs, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/cbli/. You may also
contact Shane Rowley, Esq. at Rowley
Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-cleveland-biolabs-inc-301157196.html
SOURCE Rowley Law PLLC